![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EEF1AKMT4 |
Gene summary for EEF1AKMT4 |
![]() |
Gene information | Species | Human | Gene symbol | EEF1AKMT4 | Gene ID | 110599564 |
Gene name | EEF1A lysine methyltransferase 4 | |
Gene Alias | EEF1AKMT4 | |
Cytomap | 3q27.1 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
110599564 | EEF1AKMT4 | LZE2T | Human | Esophagus | ESCC | 4.73e-03 | 6.08e-01 | 0.082 |
110599564 | EEF1AKMT4 | LZE4T | Human | Esophagus | ESCC | 6.68e-22 | 6.08e-01 | 0.0811 |
110599564 | EEF1AKMT4 | LZE5T | Human | Esophagus | ESCC | 1.48e-05 | 3.63e-01 | 0.0514 |
110599564 | EEF1AKMT4 | LZE7T | Human | Esophagus | ESCC | 2.56e-05 | 2.67e-01 | 0.0667 |
110599564 | EEF1AKMT4 | LZE8T | Human | Esophagus | ESCC | 2.72e-03 | 2.12e-01 | 0.067 |
110599564 | EEF1AKMT4 | LZE20T | Human | Esophagus | ESCC | 4.88e-05 | 1.97e-01 | 0.0662 |
110599564 | EEF1AKMT4 | LZE21D1 | Human | Esophagus | HGIN | 5.38e-03 | 3.63e-01 | 0.0632 |
110599564 | EEF1AKMT4 | LZE22T | Human | Esophagus | ESCC | 1.40e-06 | 5.38e-01 | 0.068 |
110599564 | EEF1AKMT4 | LZE24T | Human | Esophagus | ESCC | 8.01e-19 | 4.62e-01 | 0.0596 |
110599564 | EEF1AKMT4 | LZE21T | Human | Esophagus | ESCC | 1.37e-06 | 3.87e-01 | 0.0655 |
110599564 | EEF1AKMT4 | LZE6T | Human | Esophagus | ESCC | 3.01e-06 | 4.38e-01 | 0.0845 |
110599564 | EEF1AKMT4 | ATC12 | Human | Thyroid | ATC | 5.14e-03 | 9.59e-02 | 0.34 |
110599564 | EEF1AKMT4 | ATC2 | Human | Thyroid | ATC | 1.60e-07 | 5.38e-01 | 0.34 |
110599564 | EEF1AKMT4 | ATC4 | Human | Thyroid | ATC | 1.97e-05 | 1.60e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00182057 | Esophagus | HGIN | peptidyl-lysine modification | 88/2587 | 376/18723 | 2.99e-07 | 1.39e-05 | 88 |
GO:00064798 | Esophagus | HGIN | protein methylation | 38/2587 | 181/18723 | 5.05e-03 | 4.22e-02 | 38 |
GO:00082138 | Esophagus | HGIN | protein alkylation | 38/2587 | 181/18723 | 5.05e-03 | 4.22e-02 | 38 |
GO:00180227 | Esophagus | HGIN | peptidyl-lysine methylation | 29/2587 | 131/18723 | 6.22e-03 | 4.95e-02 | 29 |
GO:001820514 | Esophagus | ESCC | peptidyl-lysine modification | 259/8552 | 376/18723 | 3.90e-20 | 5.26e-18 | 259 |
GO:00434143 | Esophagus | ESCC | macromolecule methylation | 199/8552 | 316/18723 | 3.44e-10 | 9.57e-09 | 199 |
GO:00322592 | Esophagus | ESCC | methylation | 222/8552 | 364/18723 | 2.26e-09 | 5.09e-08 | 222 |
GO:000647914 | Esophagus | ESCC | protein methylation | 115/8552 | 181/18723 | 9.07e-07 | 1.16e-05 | 115 |
GO:000821314 | Esophagus | ESCC | protein alkylation | 115/8552 | 181/18723 | 9.07e-07 | 1.16e-05 | 115 |
GO:001802214 | Esophagus | ESCC | peptidyl-lysine methylation | 79/8552 | 131/18723 | 5.17e-04 | 2.86e-03 | 79 |
GO:001820516 | Thyroid | ATC | peptidyl-lysine modification | 193/6293 | 376/18723 | 6.92e-13 | 3.06e-11 | 193 |
GO:000647916 | Thyroid | ATC | protein methylation | 85/6293 | 181/18723 | 1.27e-04 | 9.00e-04 | 85 |
GO:000821316 | Thyroid | ATC | protein alkylation | 85/6293 | 181/18723 | 1.27e-04 | 9.00e-04 | 85 |
GO:004341412 | Thyroid | ATC | macromolecule methylation | 131/6293 | 316/18723 | 2.01e-03 | 9.60e-03 | 131 |
GO:003225911 | Thyroid | ATC | methylation | 148/6293 | 364/18723 | 2.69e-03 | 1.23e-02 | 148 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |